HIGHBuilt-inProduct / Revenue mix
71.3%
Food Safety segment
“10-K Item 1: 'Revenues from Neogen’s Food Safety segment accounted for 71.3%, 70.9%, and 66.5% of our total revenues'”
NEOG · Concentration risk · 10-K extracted
Neogen (NEOG) concentration risks
Updated
The most significant concentration Neogen discloses is Food Safety segment at 71.3%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Neogen’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 3 disclosed concentrations
HIGH3
MEDIUM0
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
HIGHBuilt-inGeographic
50.2%
customers outside the U.S.
“10-K Item 1: 'Sales to customers outside the U.S. accounted for 50.2%, 49.7%, and 48.4% of our total revenues'”
HIGHOutside partySupplier
sole or single source supplier
“10-K Item 1A: 'Certain of our food safety product lines depend on a sole or single source supplier or vendor.'”
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-10-04Neogen's disclosed concentrations are three large-share exposures that reinforce each other. Food Safety accounted for 71.3% of total revenues (70.9% and 66.5% in other periods cited), and sales to customers outside the U.S. accounted for 50.2% (49.7% and 48.4%). Both are structural: they describe what the business is, a food-safety-led company with a global customer base, rather than a counterparty reliance. Both shares have also crept upward across the periods cited. The supply side adds an idiosyncratic risk. The 10-K says certain food safety product lines depend on a sole or single source supplier or vendor, a dependency with no disclosed percentage. Because Food Safety is the largest segment, a supplier disruption would land on the part of the business that matters most. Netting this out, the structural concentrations define the exposure to food-testing demand and international conditions, while the sole-source dependency is the item most likely to produce a company-specific surprise. All are clearly disclosed in the most recent 10-K.
For the engine’s reasoning on NEOG’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Devices
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| AORT | Artivion, Inc. | 4 | 4 | 0 | 8 |
| NEOG● | Neogen Corporation | 3 | 0 | 0 | 3 |
| ATEC | Alphatec Holdings, Inc. | 1 | 1 | 0 | 2 |
| ABT | Abbott Laboratories | 1 | 0 | 0 | 1 |
| AVR | Anteris Technologies Global Cor | 1 | 0 | 0 | 1 |
| AHCO | AdaptHealth Corp. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.